Manufacturing and Production

Showing 15 posts of 5862 posts found.

NICE rejects Roche’s Kadcyla for NHS; price still too high

November 17, 2015 Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche

NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …
Diabetes treatments

Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024

November 16, 2015 Manufacturing and Production, Research and Development diabetes, market reports

Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …
baxalta_logo

FDA approves Baxalta Haemophilia A treatment

November 16, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
mene_pangalos

New appointments for AstraZeneca’s Mene Pangalos

November 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …
Roche building

Roche manufacturing restructure means EU, US jobs cuts

November 13, 2015 Manufacturing and Production, Medical Communications Roche, job cuts, job losses, manufacturing, production, redundancies, restructure

Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …
Benlysta

GSK ready for lupus drug push

November 12, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …
MSF poster

MSF launches global action against GSK and Pfizer over pneumonia vaccine price

November 12, 2015 Manufacturing and Production, Sales and Marketing Doctors Without Borders, GSK, MSF, Médecins Sans Frontières, Pfizer, Synflorix, pneumococcal vaccine, pneumonia, prevenar 13, vaccines

International medical aid charity Médecins Sans Frontières/Doctors Without Borders (MSF) is taking action against GlaxoSmithKline and Pfizer, calling on the …
ABPI

ABPI welcomes science budget inquiry findings

November 10, 2015 Manufacturing and Production, Research and Development ABPI, Comprehensive Spending Review

The UK pharma trade body, the ABPI, has welcomed the findings of the Science and Technology Committee’s inquiry into the …
Westminster

All Party Parliamentary Group for Life Sciences CSR letter to the Chancellor, Business Secretary and Science Ministers

November 10, 2015 Manufacturing and Production, Research and Development Chancellor, Comprehensive Spending Review, George Osborne

Dear Mr Osborne,Ahead of the forthcoming Comprehensive Spending Review I am sure you will have received many letters from across …
Janssen image

Janssen buys licence to diabetes and obesity drugs from Hanmi

November 10, 2015 Manufacturing and Production, Research and Development Janssen, diabetes, hanmi

Janssen could spend up to a billion dollars to buy for novel clinical stage biologics to treat diabetes and obesity. …

FDA warnings create woe for Indian drugmakers

November 10, 2015 Manufacturing and Production CGMP, Dr Reddy's, Dr. Reddy's, FDA, India, Sun Pharma, manufacturing, production

Recent enforcement action has taken its toll on the fortunes of several Indian pharmaceutical manufacturers, with Sun Pharmaceuticals and Dr. …
flu vaccine

Sanofi Pasteur ‘actively exploring’ universal flu vaccine

November 10, 2015 Manufacturing and Production, Research and Development SEEK, Sanofi Pasteur, influenza, universal flu vaccine

Sanofi Pasteur is developing a universal, cross-reactive antigen against seasonal and pandemic influenza, the company has revealed.The French firm presented its …

Jardiance scores more cardiovascular outcomes data

November 10, 2015 Manufacturing and Production Boehringer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Victoza, cardiovascular outcomes, diabetes, empagliflozin, jardiance, lilly, liraglutide, type 2 diabetes

A sub-group analysis of data from an outcomes study of Boehringer Ingelheim’s and Lilly’s Jardiance has found the diabetes drug …
Olivier Brandicourt

Brandicourt sets out Sanofi’s long-term vision

November 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, olivier brandicourt, pharma strategy

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …
Pascale Witz Sanofi

Sanofi and Hanmi partner to create long-acting diabetes treatments

November 5, 2015 Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …
The Gateway to Local Adoption Series

Latest content